Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Cadence Pharmaceuticals Inc (CADX) since 2010 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Cadence Pharmaceuticals Inc. Table 2 shows the detailed insider transactions. This company's CIK number is 1333248.
Total stock buying since 2010: $287,195.
Total stock sales since 2010: $17,801,343.
Total stock option exercises since 2010: $41,858,263.
▪ Recent SEC 13D filings for all companies
▪ Recent portfolio reports of all companies
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2014 | 0 | $0 | 0 | $0 | 5,190,446 | $40,693,094 |
2013 | 0 | $0 | 2,853,377 | $15,833,324 | 239,928 | $822,770 |
2011 | 27,000 | $197,395 | 100,500 | $693,598 | 120,500 | $217,600 |
2010 | 10,000 | $89,800 | 159,000 | $1,274,421 | 39,000 | $124,799 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2014-02 | 0 | $0 | 0 | $0 | 5,190,446 | $40,693,094 |
2013-12 | 0 | $0 | 29,326 | $263,079 | 29,326 | $100,299 |
2013-11 | 0 | $0 | 98,472 | $731,602 | 98,472 | $334,476 |
2013-07 | 0 | $0 | 36,015 | $273,795 | 36,015 | $123,622 |
2013-06 | 0 | $0 | 80,115 | $599,734 | 76,115 | $264,373 |
2013-04 | 0 | $0 | 298,412 | $1,975,194 | 0 | $0 |
2013-03 | 0 | $0 | 699,524 | $3,659,127 | 0 | $0 |
2013-02 | 0 | $0 | 217,745 | $1,083,070 | 0 | $0 |
2013-01 | 0 | $0 | 1,393,768 | $7,247,723 | 0 | $0 |
2011-11 | 0 | $0 | 32,500 | $154,550 | 52,500 | $0 |
2011-07 | 0 | $0 | 3,000 | $26,970 | 3,000 | $9,600 |
2011-05 | 27,000 | $197,395 | 12,000 | $100,164 | 12,000 | $38,400 |
2011-04 | 0 | $0 | 7,000 | $64,399 | 7,000 | $22,400 |
2011-03 | 0 | $0 | 7,000 | $59,500 | 7,000 | $22,400 |
2011-02 | 0 | $0 | 39,000 | $288,015 | 39,000 | $124,800 |
2010-11 | 0 | $0 | 25,000 | $225,864 | 25,000 | $80,000 |
2010-10 | 0 | $0 | 16,297 | $137,167 | 7,000 | $22,400 |
2010-09 | 0 | $0 | 47,703 | $399,206 | 7,000 | $22,399 |
2010-07 | 0 | $0 | 8,979 | $62,404 | 0 | $0 |
2010-06 | 0 | $0 | 51,021 | $357,770 | 0 | $0 |
2010-05 | 10,000 | $89,800 | 10,000 | $92,010 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2014-02-12 | Atwood Brian G (Director) | Option Ex | 695,168 | 7.84 | 5,450,117 |
2014-02-12 | Schoemaker Kathleen K (10% Owner) | Option Ex | 1,390,337 | 7.84 | 10,900,241 |
2014-02-12 | Frazier Alan D (Director) | Option Ex | 1,737,921 | 7.84 | 13,625,300 |
2013-12-17 | Larue William R (SVP, CFO, Treas, Asst Sec) | Sale | 8,500 | 9.12 | 77,520 |
2013-12-17 | Larue William R (SVP, CFO, Treas, Asst Sec) | Option Ex | 8,500 | 3.20 | 27,200 |
2013-12-16 | Aker Hazel M (SVP, GC & Secretary) | Sale | 13,014 | 8.76 | 114,002 |
2013-12-16 | Aker Hazel M (SVP, GC & Secretary) | Option Ex | 13,014 | 3.51 | 45,679 |
2013-12-02 | Byrd Scott A. (SVP, Chief Commercial Officer) | Sale | 7,812 | 9.16 | 71,557 |
2013-12-02 | Byrd Scott A. (SVP, Chief Commercial Officer) | Option Ex | 7,812 | 3.51 | 27,420 |
2013-11-18 | Larue William R (SVP, CFO, Treas, Asst Sec) | Sale | 9,000 | 7.60 | 68,400 |
2013-11-18 | Larue William R (SVP, CFO, Treas, Asst Sec) | Option Ex | 9,000 | 3.20 | 28,800 |
2013-11-15 | Byrd Scott A. (SVP, Chief Commercial Officer) | Sale | 10,416 | 8.00 | 83,328 |
2013-11-15 | Byrd Scott A. (SVP, Chief Commercial Officer) | Option Ex | 10,416 | 3.51 | 36,560 |
2013-11-15 | Larue William R (SVP, CFO, Treas, Asst Sec) | Sale | 27,000 | 7.20 | 194,400 |
2013-11-15 | Larue William R (SVP, CFO, Treas, Asst Sec) | Option Ex | 27,000 | 3.20 | 86,400 |
2013-11-15 | Aker Hazel M (SVP, GC & Secretary) | Sale | 52,056 | 7.41 | 385,474 |
2013-11-15 | Aker Hazel M (SVP, GC & Secretary) | Option Ex | 52,056 | 3.51 | 182,716 |
2013-07-22 | Lloyd-smith Malcolm (SVP, Reg Affairs, Qual & Clin) | Sale | 14,000 | 7.85 | 109,900 |
2013-07-22 | Lloyd-smith Malcolm (SVP, Reg Affairs, Qual & Clin) | Option Ex | 14,000 | 3.51 | 49,140 |
2013-07-22 | Aker Hazel M (SVP, GC & Secretary) | Sale | 6,507 | 7.81 | 50,819 |
2013-07-22 | Aker Hazel M (SVP, GC & Secretary) | Option Ex | 6,507 | 3.51 | 22,839 |
2013-07-17 | Larue William R (SVP, CFO, Treas, Asst Sec) | Sale | 9,000 | 7.25 | 65,295 |
2013-07-17 | Larue William R (SVP, CFO, Treas, Asst Sec) | Option Ex | 9,000 | 3.20 | 28,800 |
2013-07-15 | Aker Hazel M (SVP, GC & Secretary) | Sale | 6,508 | 7.34 | 47,781 |
2013-07-15 | Aker Hazel M (SVP, GC & Secretary) | Option Ex | 6,508 | 3.51 | 22,843 |
2013-06-27 | Larue William R (SVP, CFO, Treas, Asst Sec) | Sale | 5,740 | 7.20 | 41,328 |
2013-06-27 | Larue William R (SVP, CFO, Treas, Asst Sec) | Option Ex | 5,740 | 3.20 | 18,368 |
2013-06-25 | Larue William R (SVP, CFO, Treas, Asst Sec) | Sale | 3,260 | 7.20 | 23,472 |
2013-06-25 | Larue William R (SVP, CFO, Treas, Asst Sec) | Option Ex | 3,260 | 3.20 | 10,432 |
2013-06-10 | Lloyd-smith Malcolm (SVP, Reg Affairs, Qual & Clin) | Sale | 4,000 | 7.44 | 29,760 |
2013-06-07 | Byrd Scott A. (SVP, Chief Commercial Officer) | Sale | 67,115 | 7.53 | 505,174 |
2013-06-07 | Byrd Scott A. (SVP, Chief Commercial Officer) | Option Ex | 67,115 | 3.51 | 235,573 |
2013-04-15 | Schoemaker Kathleen K (10% Owner) | Sale | 94,788 | 6.62 | 627,496 |
2013-04-10 | Schoemaker Kathleen K (10% Owner) | Sale | 6,399 | 6.72 | 43,001 |
2013-04-09 | Schoemaker Kathleen K (10% Owner) | Sale | 46,500 | 6.71 | 312,014 |
2013-04-08 | Schoemaker Kathleen K (10% Owner) | Sale | 49,893 | 6.52 | 325,301 |
2013-03-21 | Schoemaker Kathleen K (10% Owner) | Sale | 20,500 | 5.38 | 110,042 |
2013-03-20 | Schoemaker Kathleen K (10% Owner) | Sale | 22,779 | 5.22 | 118,905 |
2013-03-19 | Schoemaker Kathleen K (10% Owner) | Sale | 32,762 | 5.19 | 170,032 |
2013-03-18 | Schoemaker Kathleen K (10% Owner) | Sale | 33,156 | 5.16 | 171,083 |
2013-03-15 | Schoemaker Kathleen K (10% Owner) | Sale | 39,836 | 5.28 | 210,333 |
2013-03-14 | Schoemaker Kathleen K (10% Owner) | Sale | 20,751 | 5.36 | 111,223 |
2013-03-13 | Schoemaker Kathleen K (10% Owner) | Sale | 31,968 | 5.40 | 172,626 |
2013-03-12 | Schoemaker Kathleen K (10% Owner) | Sale | 26,232 | 5.38 | 141,126 |
2013-03-11 | Schoemaker Kathleen K (10% Owner) | Sale | 17,024 | 5.34 | 90,907 |
2013-03-08 | Schoemaker Kathleen K (10% Owner) | Sale | 21,305 | 5.32 | 113,341 |
2013-03-07 | Schoemaker Kathleen K (10% Owner) | Sale | 52,504 | 5.22 | 274,069 |
2013-03-06 | Schoemaker Kathleen K (10% Owner) | Sale | 15,872 | 5.06 | 80,310 |
2013-03-05 | Schoemaker Kathleen K (10% Owner) | Sale | 16,696 | 5.01 | 83,645 |
2013-03-04 | Schoemaker Kathleen K (10% Owner) | Sale | 21,268 | 5.01 | 106,550 |
2013-03-01 | Schoemaker Kathleen K (10% Owner) | Sale | 31,566 | 5.01 | 158,144 |
2013-02-20 | Schoemaker Kathleen K (10% Owner) | Sale | 8,258 | 5.01 | 41,370 |
2013-02-19 | Schoemaker Kathleen K (10% Owner) | Sale | 41,656 | 5.02 | 209,111 |
2013-02-15 | Schoemaker Kathleen K (10% Owner) | Sale | 12,265 | 5.00 | 61,325 |
2013-02-14 | Schoemaker Kathleen K (10% Owner) | Sale | 12,200 | 5.01 | 61,120 |
2013-02-13 | Schoemaker Kathleen K (10% Owner) | Sale | 23,822 | 5.00 | 119,110 |
2013-02-01 | Schoemaker Kathleen K (10% Owner) | Sale | 40,389 | 4.85 | 195,884 |
2013-01-31 | Schoemaker Kathleen K (10% Owner) | Sale | 76,629 | 4.71 | 360,921 |
2013-01-30 | Schoemaker Kathleen K (10% Owner) | Sale | 45,908 | 5.00 | 229,540 |
2013-01-29 | Schoemaker Kathleen K (10% Owner) | Sale | 63,334 | 5.27 | 333,768 |
2013-01-28 | Schoemaker Kathleen K (10% Owner) | Sale | 68,870 | 5.40 | 371,896 |
2013-01-25 | Schoemaker Kathleen K (10% Owner) | Sale | 57,005 | 5.38 | 306,685 |
2013-01-24 | Schoemaker Kathleen K (10% Owner) | Sale | 149,163 | 5.45 | 812,936 |
2013-01-23 | Schoemaker Kathleen K (10% Owner) | Sale | 104,811 | 5.11 | 535,582 |
2013-01-22 | Schoemaker Kathleen K (10% Owner) | Sale | 61,868 | 5.02 | 310,576 |
2013-01-18 | Schoemaker Kathleen K (10% Owner) | Sale | 78,873 | 5.19 | 409,349 |
2013-01-17 | Schoemaker Kathleen K (10% Owner) | Sale | 52,150 | 5.35 | 279,001 |
2011-11-21 | Larue William R (SVP, CFO, Treas, Asst Sec) | Sale | 10,000 | 4.16 | 41,630 |
2011-11-21 | Aker Hazel M (SVP, GC & Secretary) | Sale | 10,000 | 4.16 | 41,620 |
2011-11-03 | Breitmeyer James B (EVP, CMO) | Sale | 12,500 | 5.70 | 71,300 |
2011-11-02 | Schroeder Theodore R (President, CEO) | Option Ex | 20,000 | .00 | 0 |
2011-11-02 | Larue William R (SVP, CFO, Treas, Asst Sec) | Option Ex | 10,000 | .00 | 0 |
2011-11-02 | Aker Hazel M (SVP, GC & Secretary) | Option Ex | 10,000 | .00 | 0 |
2011-11-02 | Breitmeyer James B (EVP, CMO) | Option Ex | 12,500 | .00 | 0 |
2011-07-11 | Breitmeyer James B (EVP, CMO) | Sale | 3,000 | 8.99 | 26,970 |
2011-07-11 | Breitmeyer James B (EVP, CMO) | Option Ex | 3,000 | 3.20 | 9,600 |
2011-05-17 | Schroeder Theodore R (President, CEO) | Buy | 16,000 | 7.48 | 119,632 |
2011-05-10 | Byrd Scott A. (SVP, Chief Commercial Officer) | Buy | 2,000 | 7.21 | 14,430 |
2011-05-10 | Barker Sam L (Director) | Buy | 9,000 | 7.04 | 63,333 |
2011-05-02 | Breitmeyer James B (EVP, CMO) | Sale | 12,000 | 8.35 | 100,164 |
2011-05-02 | Breitmeyer James B (EVP, CMO) | Option Ex | 12,000 | 3.20 | 38,400 |
2011-04-01 | Breitmeyer James B (EVP, CMO) | Sale | 7,000 | 9.20 | 64,399 |
2011-04-01 | Breitmeyer James B (EVP, CMO) | Option Ex | 7,000 | 3.20 | 22,400 |
2011-03-04 | Breitmeyer James B (EVP, CMO) | Sale | 7,000 | 8.50 | 59,500 |
2011-03-04 | Breitmeyer James B (EVP, CMO) | Option Ex | 7,000 | 3.20 | 22,400 |
2011-02-03 | Breitmeyer James B (EVP, CMO) | Sale | 39,000 | 7.38 | 288,015 |
2011-02-03 | Breitmeyer James B (EVP, CMO) | Option Ex | 39,000 | 3.20 | 124,800 |
2010-11-02 | Breitmeyer James B (EVP, CMO) | Sale | 18,000 | 9.05 | 162,864 |
2010-11-02 | Breitmeyer James B (EVP, CMO) | Option Ex | 18,000 | 3.20 | 57,600 |
2010-11-01 | Breitmeyer James B (EVP, CMO) | Sale | 7,000 | 9.00 | 63,000 |
2010-11-01 | Breitmeyer James B (EVP, CMO) | Option Ex | 7,000 | 3.20 | 22,400 |
2010-10-05 | Breitmeyer James B (EVP, CMO) | Sale | 7,000 | 8.50 | 59,500 |
2010-10-05 | Breitmeyer James B (EVP, CMO) | Option Ex | 7,000 | 3.20 | 22,400 |
2010-10-01 | Schroeder Theodore R (President, CEO) | Sale | 9,297 | 8.35 | 77,667 |
2010-09-30 | Schroeder Theodore R (President, CEO) | Sale | 40,703 | 8.35 | 339,707 |
2010-09-29 | Breitmeyer James B (EVP, CMO) | Sale | 4,637 | 8.50 | 39,414 |
2010-09-29 | Breitmeyer James B (EVP, CMO) | Option Ex | 4,637 | 3.20 | 14,838 |
2010-09-27 | Breitmeyer James B (EVP, CMO) | Sale | 2,363 | 8.50 | 20,085 |
2010-09-27 | Breitmeyer James B (EVP, CMO) | Option Ex | 2,363 | 3.20 | 7,561 |
2010-07-01 | Schroeder Theodore R (President, CEO) | Sale | 8,979 | 6.95 | 62,404 |
2010-06-30 | Schroeder Theodore R (President, CEO) | Sale | 41,021 | 7.00 | 287,270 |
2010-06-14 | Socks David A (SVP) | Sale | 10,000 | 7.05 | 70,500 |
2010-05-11 | Rich Todd W (Director) | Buy | 10,000 | 8.98 | 89,800 |
2010-05-10 | Socks David A (SVP) | Sale | 10,000 | 9.20 | 92,010 |
Insider trading activities including stock purchases, stock sales, and option exercises of CADX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Cadence Pharmaceuticals Inc (symbol CADX, CIK number 1333248) see the Securities and Exchange Commission (SEC) website.